Skip to main content
Premium Trial:

Request an Annual Quote

Packard Backs out of Aclara LabCard Distribution Agreement

NEW YORK, Jan 5 - Packard BioScience has decided to terminate its collaboration with Aclara BioSciences in which it was to be the exclusive distributor of Aclara’s Arteas LabCards, a microfluidics array technology, the companies said Friday.

The companies said in a statement that the decision to end the collaboration, which began in February 2000, was made jointly.

Packard spokesman Mike Zebarth told GenomeWeb that Packard’s decision was based on the unexpected success of several products it introduced last year, namely its Fusion multimode plate-reader and AlphaScreen chemistry technology. “Those successes have presented us with a lot of new application development opportunities, and we have to prioritize where we’re going to put our resources,” he said.

“Every company makes decisions to put its resources where they’re going to make the most money, and clearly that’s on your own products as opposed to distributing other people’s products,” Zebarth said.

Aclara said the decision would benefit its own commercialization efforts as well. Packard’s decision to relinquish its exclusive rights to sell Arteas LabCards will give Aclara the opportunity to market the product to customers employing open architecture screening systems, the company said.  

" We wanted to enhance our ability to serve this segment, and this change in our agreement with Packard provides that ability,” said Joseph Limber, president and CEO of Aclara.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.